Datar Cancer Genetics launches EasyCheck Breast in collaboration with Apollo Cancer Centre

EasyCheck Breast is a giant technological leap in breast-cancer detection

Apollo Cancer Centres in association with Datar Cancer Genetics has launched a blood test ‘EasyCheck-Breast’ that can detect breast cancers at early stages in asymptomatic individuals with high accuracy, thus enabling timely diagnosis and treatment to save lives.

Apollo Cancer Centres, via this launch appeals to the women to get screened in the easiest way via a blood test to gain knowledge about their susceptibility to Breast Cancer. With an easy draw of a small quantity of blood, EasyCheck- Breast can help in the detection of breast cancer even before the first stage. It will be available across India on 22nd June at all Apollo Cancer Centres.

Commenting on the occasion, Dr Prathap Reddy, Founder & Chairman, Apollo Hospitals, said, “In line with our mission to spread awareness about early detection of cancers and offer world-class cancer treatment, the launch of EasyCheck Breast marks an important success towards quality technological advancements ensuring timely diagnosis and treatment to lower the mortality rate. This association with Datar Cancer Genetics has made a path-breaking achievement and at Apollo Cancer Centres, we are well equipped to diagnose breast cancers with the best in class advancements and treatments. I, humbly, request the caretakers of the family, the women of India, to step out for themselves and make sure to get themselves tested at least once a year to make sure you are safe from breast cancer. From diagnosis to treatment, Apollo Cancer Centres pledges to stand with their patients at all times and give them Tender Loving Care on the road to recovery.”

Speaking about the test, Rajan Datar, Founder & Chairman, Datar Cancer Genetics, said, “Unfortunately, most cancers are detected at advanced stages which necessitate more intensive and expensive treatments which have a greater risk of debilitating side effects and treatment failures. EasyCheck- Breast is the culmination of years of collaborative international research and innovation and has been developed, tested, and validated on population-sized cohorts. A simple blood draw holds the promise of early cancer detection in asymptomatic individuals and opens the possibilities of successful treatments and improved survival.”

In line with the mission to spread awareness about cancer & regular screening for early detection with EasyCheck- Breast, Apollo Cancer aims at addressing the pressing need for the right knowledge about early diagnosis, and holistic treatment in cancer care.